76 related articles for article (PubMed ID: 9042307)
41. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
42. Effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) on the liver metastasis of colon 26-L5 carcinoma cells.
Sakukawa R; Murakami K; Ikeda T; Yamada Y; Saiki I
Oncol Res; 1998; 10(6):287-93. PubMed ID: 9848099
[TBL] [Abstract][Full Text] [Related]
43. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
[TBL] [Abstract][Full Text] [Related]
44. Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.
Breistøl K; Balzarini J; Sandvold ML; Myhren F; Martinsen M; De Clercq E; Fodstad O
Cancer Res; 1999 Jun; 59(12):2944-9. PubMed ID: 10383159
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone.
Elkin M; Reich R; Nagler A; Aingorn E; Pines M; de-Groot N; Hochberg A; Vlodavsky I
Clin Cancer Res; 1999 Aug; 5(8):1982-8. PubMed ID: 10473075
[TBL] [Abstract][Full Text] [Related]
46. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer.
Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Ojima T; Yamaue H
Surgery; 2003 Mar; 133(3):309-17. PubMed ID: 12660644
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
[TBL] [Abstract][Full Text] [Related]
48. Histological bioanalysis for therapeutic effects of hybrid liposomes on the hepatic metastasis of colon carcinoma in vivo.
Ichihara H; Funamoto K; Matsushita T; Matsumoto Y; Ueoka R
Int J Pharm; 2010 Jul; 394(1-2):174-8. PubMed ID: 20471463
[TBL] [Abstract][Full Text] [Related]
49. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
Prajda N; Hata Y; Abonyi M; Singhal RL; Weber G
Cancer Res; 1993 Dec; 53(24):5982-6. PubMed ID: 7903199
[TBL] [Abstract][Full Text] [Related]
50. Effectiveness of tiazofurin (NSC 286193) in treating disseminated tumor cells and micrometastases in mice.
Lapis K; Pápay J; Paku S
Oncology; 1990; 47(4):359-64. PubMed ID: 2367062
[TBL] [Abstract][Full Text] [Related]
51. Modulation of membrane phenotype, matrix adhesion and microinvasiveness of metastatic tumour cells by HUdR.
Timár J; Pogány G; Balázs M; Szöllösi J; Ladányi A; Oláh J; Timár F; Lapis K; Jeney A
Cell Biochem Funct; 1990 Oct; 8(4):211-20. PubMed ID: 2272119
[TBL] [Abstract][Full Text] [Related]
52. Glycosaminoglycans as novel target in antitumor therapy.
Jeney A; Timár J; Pogány G; Paku S; Moczár E; Mareel M; Otvös L; Kopper L; Lapis K
Tokai J Exp Clin Med; 1990 May; 15(2-3):167-77. PubMed ID: 2130525
[TBL] [Abstract][Full Text] [Related]
53. Antitumor activity of tiazofurin in human colon carcinoma HT-29.
Zhen W; Jayaram HN; Weber G
Cancer Invest; 1992; 10(6):505-11. PubMed ID: 1358409
[TBL] [Abstract][Full Text] [Related]
54. Growth inhibition and induction of phenotypic alterations by tiazofurin: differential effects on MCF-7 breast cancer and HBL-100 breast cell lines.
Sidi Y; Beery E; Panet C; Wasserman L; Novogrodsky A; Nordenberg J
Eur J Cancer Clin Oncol; 1989 May; 25(5):883-9. PubMed ID: 2737221
[TBL] [Abstract][Full Text] [Related]
55. Tiazofurin enhances the anabolism and toxicity of 5-fluorouracil.
Cysyk RL; Chisena CA; Hyman R; Monks A
Cancer Lett; 1996 Dec; 109(1-2):49-55. PubMed ID: 9020902
[TBL] [Abstract][Full Text] [Related]
56. Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166.
Oba K; Konno H; Tanaka T; Baba M; Kamiya K; Ohta M; Kaneko T; Shouji T; Igarashi A; Nakamura S
Cancer Lett; 2002 Jan; 175(1):45-51. PubMed ID: 11734335
[TBL] [Abstract][Full Text] [Related]
57. Characterization of an animal model of metastatic colon carcinoma.
Dunnington DJ; Buscarino C; Gennaro D; Greig R; Poste G
Int J Cancer; 1987 Feb; 39(2):248-54. PubMed ID: 3804494
[TBL] [Abstract][Full Text] [Related]
58. Role of differentiation induction in action of purine antimetabolites.
Weber G; Hata Y; Prajda N
Pharm World Sci; 1994 Apr; 16(2):77-83. PubMed ID: 8032345
[TBL] [Abstract][Full Text] [Related]
59. Growth of human colorectal tumor xenografts in immunosuppressed mice reconstituted with normal cells.
Kopper L; Van Hanh T; Hegedüs C; Lapis K
Exp Cell Biol; 1981; 49(3):141-7. PubMed ID: 6972884
[TBL] [Abstract][Full Text] [Related]
60. A new synthetic methodology for tiazofurin.
Ramasamy KS; Lau JY
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1329-31. PubMed ID: 11563015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
